Recap: Vir Biotechnology Q4 Earnings


Vir Biotechnology VIR reported its Q4 earnings results on Thursday, February 22, 2024 at 04:05 PM.

Here's what investors need to know about the announcement.


Vir Biotechnology beat estimated earnings by 14.85%, reporting an EPS of $-0.86 versus an estimate of $-1.01.

Revenue was down $32.62 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.01 which was followed by a 6.96% increase in the share price the next day.

Here's a look at Vir Biotechnology's past performance:

Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022
EPS Estimate -1.21 -1.20 -0.87 -0.39
EPS Actual -1.22 -1.45 -1.06 -0.76
Revenue Estimate 10.24M 25.89M 51.53M 97.30M
Revenue Actual 2.64M 3.80M 62.96M 49.41M

To track all earnings releases for Vir Biotechnology visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!